Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RNH1 Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)

RNH1 Origine: Humain Hôte: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
N° du produit ABIN2730897
  • Antigène Voir toutes RNH1 Protéines
    RNH1 (Ribonuclease/angiogenin Inhibitor 1 (RNH1))
    Type de proteíne
    Recombinant
    Attributs du protein
    Transcript Variant 1
    Origine
    • 10
    • 3
    • 3
    • 1
    • 1
    Humain
    Source
    • 6
    • 5
    • 3
    • 2
    • 2
    HEK-293 Cells
    Purification/Conjugué
    Cette RNH1 protéine est marqué à la Myc-DYKDDDDK Tag.
    Application
    Antibody Production (AbP), Standard (STD)
    Attributs du produit
    • Recombinant human Ribonuclease inhibitor (RNH1) (transcript variant 1) protein expressed in HEK293 cells.
    • Produced with end-sequenced ORF clone
    Pureté
    > 80 % as determined by SDS-PAGE and Coomassie blue staining
    Top Product
    Discover our top product RNH1 Protéine
  • Indications d'application
    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays
    Commentaires

    The tag is located at the C-terminal.

    Restrictions
    For Research Use only
  • Concentration
    50 μg/mL
    Buffer
    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
    Stock
    -80 °C
    Stockage commentaire
    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Ascione, Rowlinson, Avolio, Katare, Meloni, Spencer, Mangialardi, Norris, Kränkel, Spinetti, Emanueli, Madeddu: "Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction." dans: Stem cell research & therapy, Vol. 6, pp. 53, (2015) (PubMed).

  • Antigène
    RNH1 (Ribonuclease/angiogenin Inhibitor 1 (RNH1))
    Autre désignation
    Ribonuclease Inhibitor (Rnh1) (RNH1 Produits)
    Synonymes
    RAI Protein, RNH Protein, AW546468 Protein, C80305 Protein, RNH1 Protein, Rnh Protein, Rnh1 Protein, im:7039360 Protein, si:ch211-213a13.3 Protein, wu:fd55g05 Protein, ribonuclease/angiogenin inhibitor 1 Protein, ribonuclease inhibitor Protein, RNH1 Protein, Rnh1 Protein, Tc00.1047053511893.10 Protein, Tc00.1047053507583.70 Protein, rnh1 Protein
    Sujet
    Placental ribonuclease inhibitor (PRI) is a member of a family of proteinaceous cytoplasmic RNase inhibitors that occur in many tissues and bind to both intracellular and extracellular RNases (summarized by Lee et al., 1988 [PubMed 3219362]). In addition to control of intracellular RNases, the inhibitor may have a role in the regulation of angiogenin (MIM 105850). Ribonuclease inhibitor, of 50,000 Da, binds to ribonucleases and holds them in a latent form. Since neutral and alkaline ribonucleases probably play a critical role in the turnover of RNA in eukaryotic cells, RNH may be essential for control of mRNA turnover the interaction of eukaryotic cells with ribonuclease may be reversible in vivo.[supplied by OMIM, Jul 2010].
    Poids moléculaire
    49.8 kDa
    NCBI Accession
    NP_002930
Vous êtes ici:
Support technique